Dr. Mark E. Morin, MD

Dr. Morin practices at Northern Light AR Gould Hospital in Presque Isle, Maine, part of Northern Light Health.

Dr. Morin's NPI, 1164512026, was assigned on October 13, 2006. Dr. Morin graduated from Stanford University School of Medicine in 1990. Dr. Morin holds Maine license MD15441.

Dr. Morin's primary practice is Northern Light AR Gould Hospital, at PO Box 151, Presque Isle, ME 04769 in Aroostook County. The practice phone is (207) 768-4000. Dr. Morin also practices at Northern Light AR Gould Hospital, 140 Academy St, Presque Isle, ME 04769.

Dr. Morin's primary practice is Northern Light AR Gould Hospital in Presque Isle, Maine, part of Northern Light Health. The medical group on file is Northern Light AR Gould Hospital. Dmand AI also links Dr. Morin to 1 more group practice or clinic and 1 medical group, each named with a free account. Dr. Morin's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Morin practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Morin's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dmand AI has Dr. Morin's licenses on file in 2 states: Maine and North Dakota.

CMS data shows 694 Medicare services from Dr. Morin across 10 procedure codes in 2024, for 227 Medicare patients. Medicare paid $25,579 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 227 Medicare patients who saw Dr. Morin in 2024. The largest group is 75 to 84, with 91 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Morin's median patient age at 73, with 54% women.

In 2024, Dr. Morin wrote 1,024 Medicare Part D claims for 338 patients. 59% of them were for generic drugs. CMS names the drug for 942 of them, across 17 drugs with 11 or more claims each, at $112,921 in total drug cost. In 2023, CMS named 1,681 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Morin for performance year 2024, reported as part of a group. Dr. Morin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 2 general payments to Dr. Morin from 2 drug and device companies from 2017 to 2019. Food and beverage make up the largest share, 100% of the total. Carl Zeiss Meditec, Inc. paid the most, $149.

Dr. Morin graduated from Stanford University School of Medicine in 1990.